AIM
GH icon

Artemis Investment Management’s Guardant Health GH Stock Holding History

Artemis Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-60,397
Closed -$3.25M – 241
2022
Q3 		$3.25M Sell
60,397
-62,100
-51% -$3.19M 0.04% 187
2022
Q2 		$4.95M Sell
122,497
-409,093
-77% -$20.3M 0.05% 185
2022
Q1 		$35.1M Buy
531,590
+242,223
+84% +$16.6M 0.28% 101
2021
Q4 		$28.9M Buy
+289,367
New +$29.9M 0.21% 123

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Artemis Investment Management's GH Position: Q4 2022 in Review

Artemis Investment Management sold out of Guardant Health (GH) in Q4 2022, closing a stake of 60,397 shares — an estimated $3.25M sold.

Artemis Investment Management first reported a position in GH in Q4 2021 and held it in 4 quarters. The position peaked at $35.1M in Q1 2022. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Artemis Investment Management reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Artemis Investment Management sold 60,397 Guardant Health shares in Q4 2022, an estimated $3.25M.
  • Artemis Investment Management first reported a position in Guardant Health in Q4 2021 and held it in 4 quarters.
  • Artemis Investment Management's Guardant Health position peaked at $35.1M in Q1 2022.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Artemis Investment Management's 13F filing for Q4 2022, filed 25 Jan 2023.